The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Antimicrobial Peptides and Proteins: From Nature’s Reservoir to the Laboratory and Beyond
Open accessAbstract
Rapid rise of antimicrobial resistance against conventional antimicrobials, resurgence of multidrug resistant microbes and the slowdown in the development of new classes of antimicrobials, necessitates the urgent development of alternate classes of therapeutic molecules. Antimicrobial peptides (AMPs) are small proteins present in different lifeforms in nature that provide defense against microbial infections. They have been effective components of the host defense system for a very long time. The fact that the development of resistance by the microbes against the AMPs is relatively slower or delayed compared to that against the conventional antibiotics, makes them prospective alternative therapeutics of the future. Several thousands of AMPs have been isolated from various natural sources like microorganisms, plants, insects, crustaceans, animals, humans, etc. to date. However, only a few of them have been translated commercially to the market so far. This is because of some inherent drawbacks of the naturally obtained AMPs like 1) short half-life owing to the susceptibility to protease degradation, 2) inactivity at physiological salt concentrations, 3) cytotoxicity to host cells, 4) lack of appropriate strategies for sustained and targeted delivery of the AMPs. This has led to a surge of interest in the development of synthetic AMPs which would retain or improve the antimicrobial potency along with circumventing the disadvantages of the natural analogs. The development of synthetic AMPs is inspired by natural designs and sequences and strengthened by the fusion with various synthetic elements. Generation of the synthetic designs are based on various strategies like sequence truncation, mutation, cyclization and introduction of unnatural amino acids and synthons. In this review, we have described some of the AMPs isolated from the vast repertoire of natural sources, and subsequently described the various synthetic designs that have been developed based on the templates of natural AMPs or from de novo design to make commercially viable therapeutics of the future. This review entails the journey of the AMPs from their natural sources to the laboratory.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
Brogden, K. A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1098 · Cited by 5,829
Hepcidin, a urinary antimicrobial peptide synthesized in the liver
Park, C. H., Valore, E. V., Waring, A. J., & Ganz, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008922200 · Cited by 2,168
Pigeon, C., Ilyin, G., Courselaud, B., Leroyer, P., Turlin, B., Brissot, P., & Loréal, O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008923200 · Cited by 1,697 · cited 1×
“It is involved in the iron homeostasis in the body (Pigeon et al., 2001).”
BackgroundLEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity
Krause, A., Neitz, S., Mägert, H.-J., Schulz, A., Forssmann, W.-G., Schulz-Knappe, P., & Adermann, K. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01920-7 · Cited by 1,324
Arima, K., Kakinuma, A., & Tamura, G. (1968) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(68)90503-2 · Cited by 908
Antibiotic resistance in food lactic acid bacteria—a review
Mathur, S., & Singh, R. (2005) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2005.03.008 · Cited by 754 · cited 1×
“Rapidly growing antibiotic resistance (Mathur and Singh, 2005) accompanied by the slowdown of the development of the newer antibiotics (Ventola, 2015) in the recent past, is a reason for major concern.”
BackgroundAureobasidins, new antifungal antibiotics. Taxonomy, fermentation, isolation, and properties.
TAKESAKO, K., IKAI, K., HARUNA, F., ENDO, M., SHIMANAKA, K., SONO, E., NAKAMURA, T., KATO, I., & YAMAGUCHI, H. (1991) · The Journal of Antibiotics · doi:10.7164/antibiotics.44.919 · Cited by 149
Structural Studies on the Forward and Reverse Binding Modes of Peptides to the Chaperone DnaK
Zahn, M., Berthold, N., Kieslich, B., Knappe, D., Hoffmann, R., & Sträter, N. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.03.041 · Cited by 126
Bagheri, M., Nikolenko, H., Arasteh, S., Rezaei, N., Behzadi, M., Dathe, M., & Hancock, R. E. W. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c04336 · Cited by 31
Cited by
Antimicrobial peptides for combating drug-resistant bacterial infections
Xuan, J., Feng, W., Wang, J., Wang, R., Zhang, B., Bo, L., Chen, Z.-S., Yang, H., & Sun, L. (2023) · Drug Resistance Updates · doi:10.1016/j.drup.2023.100954 · Cited by 665
Antimicrobial Peptides—Mechanisms of Action, Antimicrobial Effects and Clinical Applications
Talapko, J., Meštrović, T., Juzbašić, M., Tomas, M., Erić, S., Horvat Aleksijević, L., Bekić, S., Schwarz, D., Matić, S., Neuberg, M., et al. (2022) · Antibiotics · doi:10.3390/antibiotics11101417 · Cited by 281
Metadata
- Authors
- Sarkar, T., Chetia, M., & Chatterjee, S.
- Venue
- Frontiers in Chemistry
- Publisher
- Frontiers Media SA
- Published
- 2021-06-18
- Volume
- 9
- Pages
- 691532-691532
- ISSN
- 2296-2646 (ISSN-L)
- OpenAlex
- W3176920788
- Cited by
- 214
- References
- 9
- FWCI
- 17.34
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antimicrobial Peptides and Proteins: From Nature’s Reservoir to the Laboratory and Beyond. https://app.cochat.ai/papers/10.3389/fchem.2021.691532
- The paper
- Sarkar, T., Chetia, M., & Chatterjee, S. (2021). Antimicrobial Peptides and Proteins: From Nature’s Reservoir to the Laboratory and Beyond. Frontiers in Chemistry. https://doi.org/10.3389/fchem.2021.691532
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.